Imaging COPD phenotypes
Nature Medicine
October 8, 2012
An imaging technique that detects subtypes of chronic obstructive pulmonary disease (COPD), is reported in a paper published online this week in Nature Medicine. This approach can provide a more accurate diagnosis and help tailor treatments for each individual to appropriately target the lung damage in COPD.
COPD is characterized by narrowing of the small airways in the lung and limiting airway flow and is not fully reversible. It is caused by lung tissue destruction, emphysema, or other functional diseases of the airways.
Brian Ross and colleagues developed an imaging biomarker that can help in differentiating between the types of disease found in the small airways, which previously could not be done with conventional physiological pulmonary tests. The authors created a computed tomography (CT)-based imaging biomarker that identifies COPD severity, phenotype, and location of disease by comparing inspiratory and expiratory CT scans on local variations in lung function.
doi: 10.1038/nm.2971
Research highlights
-
Jul 6
Biotechnology: Mice cloned from freeze-dried somatic cellsNature Communications
-
Jul 4
Particle physics: A decade of Higgs boson researchNature
-
Jul 1
Space health: The path of most resistance could help limit bone loss during spaceflightScientific Reports
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 28
Astronomy: Hydrogen- and helium-rich exoplanets may provide habitable conditions for billions of yearsNature Astronomy
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports